Wolverine Trading’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $43.8K | Buy |
+31,500
| New | +$35.7K | ﹤0.01% | 5444 |
|
|
2025
Q1 | – | Sell |
-10,100
| Closed | -$7.27K | – | 5784 |
|
|
2024
Q4 | $7.27K | Buy |
10,100
+100
| +1% | +$121 | ﹤0.01% | 5167 |
|
|
2024
Q3 | $16K | Sell |
10,000
-7,300
| -42% | -$13K | ﹤0.01% | 4659 |
|
|
2024
Q2 | $29.1K | Sell |
17,300
-3,700
| -18% | -$6.64K | ﹤0.01% | 4293 |
|
|
2024
Q1 | $50.4K | Buy |
21,000
+8,700
| +71% | +$18.7K | ﹤0.01% | 4214 |
|
|
2023
Q4 | $18.8K | Sell |
12,300
-1,100
| -8% | -$1.31K | ﹤0.01% | 4375 |
|
|
2023
Q3 | $14.6K | Sell |
13,400
-13,500
| -50% | -$23.7K | ﹤0.01% | 4352 |
|
|
2023
Q2 | $58.4K | Buy |
+26,900
| New | +$71.4K | ﹤0.01% | 3905 |
|
|
2022
Q1 | – | Sell |
-24,900
| Closed | -$104K | – | 6407 |
|
|
2021
Q4 | $104K | Buy |
24,900
+10,200
| +69% | +$49.5K | ﹤0.01% | 5079 |
|
|
2021
Q3 | $72K | Buy |
14,700
+2,800
| +24% | +$11.5K | ﹤0.01% | 5911 |
|
|
2021
Q2 | $60K | Buy |
+11,900
| New | +$57.3K | ﹤0.01% | 5565 |
|
|
2020
Q1 | – | Sell |
-10,900
| Closed | -$45K | – | 5247 |
|
|
2019
Q4 | $45K | Sell |
10,900
-8,600
| -44% | -$33.1K | ﹤0.01% | 4480 |
|
|
2019
Q3 | $67K | Sell |
19,500
-9,100
| -32% | -$28.2K | ﹤0.01% | 3979 |
|
|
2019
Q2 | $180K | Sell |
28,600
-36,100
| -56% | -$216K | 0.01% | 3770 |
|
|
2019
Q1 | $360K | Buy |
+64,700
| New | +$393K | 0.01% | 3150 |
|
|
2018
Q3 | – | Sell |
-17,500
| Closed | -$150K | – | 5767 |
|
|
2018
Q2 | $150K | Hold |
17,500
| – | – | ﹤0.01% | 4566 |
|
|
2018
Q1 | $150K | Buy |
+17,500
| New | +$162K | ﹤0.01% | 4566 |
|
|
2017
Q4 | – | Sell |
-17,000
| Closed | -$209K | – | 5468 |
|
|
2017
Q3 | $209K | Buy |
+17,000
| New | +$251K | 0.01% | 3748 |
|
Other funds holding LXRX
AG
SL
SC
